GlobeNewswire·May 5, 2026, 7:30 AM ET

Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance

Surgery Partners reported Q1 2026 revenue of $810.9 million, a 4.5% year-over-year increase from $776.0 million.
Same-facility revenue grew 4.4% in Q1 2026, driven by a 3.8% increase in revenue per case and a 0.6% rise in same-facility cases.
The company recorded a net loss of $35.9 million attributable to Surgery Partners, Inc. for the quarter.
Adjusted EBITDA for Q1 2026 was $102.3 million, down slightly from $103.9 million in the same period of 2025.
Surgery Partners reaffirmed its 2026 guidance, projecting full-year revenue between $3.35 billion and $3.45 billion and Adjusted EBITDA of at least $530 million.
As of March 31, 2026, the company held $182.3 million in cash and had $666.1 million in borrowing capacity under its revolving credit facility.
Operating cash flow for the first quarter was $11.7 million, an increase from $6.0 million in Q1 2025.
The total net debt to EBITDA ratio stood at approximately 4.3x at the end of Q1 2026.
The company operates 180 surgical facilities, including 122 consolidated facilities, as of the end of the first quarter.
Surgery Partners held a conference call on May 5, 2026, at 8:30 a.m. Eastern Time to discuss these results.